Cargando…
New Myrtenal–Adamantane Conjugates Alleviate Alzheimer’s-Type Dementia in Rat Model
Alzheimer’s disease (AD) is a neurodegenerative disease associated with memory impairment and other central nervous system (CNS) symptoms. Two myrtenal–adamantane conjugates (MACs) showed excellent CNS potential against Alzheimer’s models. Adamantane is a common pharmacophore for drug design, and my...
Autores principales: | Dragomanova, Stela, Lazarova, Maria, Munkuev, Aldar, Suslov, Evgeniy, Volcho, Konstantin, Salakhutdinov, Nariman, Bibi, Amina, Reynisson, Jóhannes, Tzvetanova, Elina, Alexandrova, Albena, Georgieva, Almira, Uzunova, Diamara, Stefanova, Miroslava, Kalfin, Reni, Tancheva, Lyubka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457974/ https://www.ncbi.nlm.nih.gov/pubmed/36080227 http://dx.doi.org/10.3390/molecules27175456 |
Ejemplares similares
-
Therapeutic Potential of Myrtenal and Its Derivatives—A Review
por: Dragomanova, Stela, et al.
Publicado: (2023) -
Neuroprotective Effects of Myrtenal in an Experimental Model of Dementia Induced in Rats
por: Dragomanova, Stela, et al.
Publicado: (2022) -
Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson’s Disease: A Comparative Study
por: Tancheva, Lyubka P., et al.
Publicado: (2020) -
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments
por: Munkuev, Aldar A., et al.
Publicado: (2021) -
Hydroxamic Acids Containing a Bicyclic Pinane Backbone as Epigenetic and Metabolic Regulators: Synergizing Agents to Overcome Cisplatin Resistance
por: Aleksandrova, Yulia, et al.
Publicado: (2023)